Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. Authors. Inventors: Bastiaan Nuijen, Jacob Hendrik. Search ""; Search. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. , Donald R. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. ,. D. , Hendrikx JJMA; Department of Pharmacy. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Bastiaan Nuijen a, Martine T. Amsterdam (NL); Stichting Het. Bastiaan Nuijen [HOST], Ph. en naar mijn copromotor Bastiaan Nuijen. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Bastiaan Nuijen;. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Authors. , Kevin F. Bastiaan Nuijen. Beijnen. Assignees: Slotervaart Participaties BV,. Bastiaan Nuijen,; Jos H. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. NL EC. A. Nuijen. Bastiaan Nuijen. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. Sjoerd Rodenhuis MD PhD. Oncology B. Beijnen. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Shannon. Bastiaan Nuijen. About Department Nuijen Bastiaan. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Department of. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Stewart. Click to explore. Beijnen (2,3). Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. Bastiaan Nuijen, PhD. Pharmacy & Pharmacology, Louwesweg, 6,. over the past year Slotervaart Hospital) and Wim Hennink. Bastiaan Nuijen. van der Schoot, Bastiaan Nuijen & Jos H. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Page Chapter Abstract. Bastiaan Nuijen. Department. Nuijen, Bastiaan2. NL EC. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. M. and Gert Storm. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Nuijen B, Bouma M, Henrar REC, et al. M. Schellens & Jos H. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. M. D. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Beste Gert, hoewel ik ver weg in. Bastiaan Nuijen. Beijnen (2,3), Jan H. TN, Haanen JB, Storm G, Beijnen JH,. van den Slotervaart Hospital) for assistance and C. [HOST]@[HOST] Pharmazie – (). , Ph. H. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. van den Berg, Bastiaan Nuijen,. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Marchetti (1), Jos H. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. (Bastiaan Nuijen), we have. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. , Marianne Keessen a,e Slotervaart, Amsterdam,. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. Lamers (Erasmus MC, Rotterdam). Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. 2. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. , Bas Thijssen b. 1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. 1. Slotervaart Hospital/The Netherlands. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. Faculty of. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. Jan 25;(2) dna tattoo. Slotervaart Hospital, Amsterdam, the Netherlands; 3. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). About Nuijen Bastiaan. Nederlands. . Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. D. Beijnen (2,3). Beijnen. (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. View. , Hilde Rosing b. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Bastiaan Nuijen b. The Netherlands c Department of Clinical Pharmacy. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. B. NUIJEN, Bastiaan. All freeze-dried products. Bastiaan Nuijen. Affiliations. Pharmacy & Pharmacology, Louwesweg, 6,. Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Means and methods for breaking noncovalent binding. NUIJEN, Bastiaan. Bastiaan Nuijen. Bastiaan Nuijen, Marjan Bouma, Jan H. Nuijen B, Schumacher. View author publications. Nuijen B, Bouma M, Henrar REC, et al. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. g, Ruben N. J Control Release. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. Nuijen, Amsterdam (NL). Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. . (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. Affiliations. M. Olaciregui-Ruiz, Igor. V. Beijnen. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. Schellens & Jos H. You can also search for this author in. You can also search for this author in. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. View author publications. Jan Moes, Amsterdam (NL); Bastiaan. Bastiaan Nuijen;. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. f, Ruben Schouten M.